These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1488479

  • 1. Growth hormone response to clonidine in male patients with panic disorder untreated by antidepressants.
    Schittecatte M, Ansseau M, Charles G, Machowski R, Papart P, Pichot W, Wilmotte J.
    Psychol Med; 1992 Nov; 22(4):1059-62. PubMed ID: 1488479
    [Abstract] [Full Text] [Related]

  • 2. Alpha 2-adrenergic receptor sensitivity in panic disorder: I. GH response to GHRH and clonidine stimulation in panic disorder.
    Brambilla F, Perna G, Garberi A, Nobile P, Bellodi L.
    Psychoneuroendocrinology; 1995 Nov; 20(1):1-9. PubMed ID: 7838898
    [Abstract] [Full Text] [Related]

  • 3. Growth-hormone response to clonidine in panic disorder patients in comparison to patients with major depression and healthy controls.
    Gann H, Riemann D, Stoll S, Berger M, Müller WE.
    Pharmacopsychiatry; 1995 May; 28(3):80-3. PubMed ID: 7568369
    [Abstract] [Full Text] [Related]

  • 4. Blunted growth hormone responses to growth hormone-releasing factor and to clonidine in panic disorder.
    Tancer ME, Stein MB, Black B, Uhde TW.
    Am J Psychiatry; 1993 Feb; 150(2):336-7. PubMed ID: 8422091
    [Abstract] [Full Text] [Related]

  • 5. Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers.
    Uhde TW, Tancer ME, Rubinow DR, Roscow DB, Boulenger JP, Vittone B, Gurguis G, Geraci M, Black B, Post RM.
    Neuropsychopharmacology; 1992 Feb; 6(2):101-18. PubMed ID: 1610485
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone response to intravenous clonidine in social phobia: comparison to patients with panic disorder and healthy volunteers.
    Tancer ME, Stein MB, Uhde TW.
    Biol Psychiatry; 1993 Nov 01; 34(9):591-5. PubMed ID: 8292687
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Persistence of blunted human growth hormone response to clonidine in fluoxetine-treated patients with panic disorder.
    Coplan JD, Papp LA, Martinez J, Pine D, Rosenblum LA, Cooper T, Liebowitz MR, Gorman JM.
    Am J Psychiatry; 1995 Apr 01; 152(4):619-22. PubMed ID: 7694915
    [Abstract] [Full Text] [Related]

  • 9. Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder.
    Kellner M, Yassouridis A, Jahn H, Wiedemann K.
    Psychopharmacology (Berl); 1997 Sep 01; 133(1):55-61. PubMed ID: 9335081
    [Abstract] [Full Text] [Related]

  • 10. Clinical response to clonidine and imipramine, and platelet alpha 2-adrenoreceptors in a case of agoraphobia with panic attacks.
    Zelnik TC, Garcia-Sevilla JA, Cameron OG, Smith CB.
    Biol Psychiatry; 1982 Jun 01; 17(6):761-6. PubMed ID: 6285996
    [No Abstract] [Full Text] [Related]

  • 11. Clonidine in panic disorder.
    Puzantian T, Hart LL.
    Ann Pharmacother; 1993 Nov 01; 27(11):1351-3. PubMed ID: 8286808
    [No Abstract] [Full Text] [Related]

  • 12. Endocrine, cardiovascular, and behavioral responses to clonidine in patients with panic disorder.
    Abelson JL, Glitz D, Cameron OG, Lee MA, Bronzo M, Curtis GC.
    Biol Psychiatry; 1992 Jul 01; 32(1):18-25. PubMed ID: 1391293
    [Abstract] [Full Text] [Related]

  • 13. Growth hormone response to clonidine in panic disorder patients.
    Schittecatte M, Charles G, Depauw Y, Mesters P, Wilmotte J.
    Psychiatry Res; 1988 Feb 01; 23(2):147-51. PubMed ID: 3363023
    [Abstract] [Full Text] [Related]

  • 14. Behavioral and physiologic effects of short-term and long-term administration of clonidine in panic disorder.
    Uhde TW, Stein MB, Vittone BJ, Siever LJ, Boulenger JP, Klein E, Mellman TA.
    Arch Gen Psychiatry; 1989 Feb 01; 46(2):170-7. PubMed ID: 2643934
    [Abstract] [Full Text] [Related]

  • 15. Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.
    Charney DS, Heninger GR, Sternberg DE, Hafstad KM, Giddings S, Landis DH.
    Arch Gen Psychiatry; 1982 Mar 01; 39(3):290-4. PubMed ID: 6279050
    [Abstract] [Full Text] [Related]

  • 16. Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder.
    Coplan JD, Papp LA, Pine D, Martinez J, Cooper T, Rosenblum LA, Klein DF, Gorman JM.
    Arch Gen Psychiatry; 1997 Jul 01; 54(7):643-8. PubMed ID: 9236548
    [Abstract] [Full Text] [Related]

  • 17. Clonidine in respiratory panic disorder subtype.
    Valença AM, Nardi AE, Mezzasalma MA, Nascimento I, Lopes FL, Zin WA, Versiani M.
    Arq Neuropsiquiatr; 2004 Jun 01; 62(2B):396-8. PubMed ID: 15273833
    [Abstract] [Full Text] [Related]

  • 18. Alpha 2-adrenoceptor sensitivity in anorexia nervosa: GH response to clonidine or GHRH stimulation.
    Brambilla F, Ferrari E, Cavagnini F, Invitti C, Zanoboni A, Massironi R, Catalano M, Cocchi D, Müller EE.
    Biol Psychiatry; 1989 Feb 01; 25(3):256-64. PubMed ID: 2536561
    [Abstract] [Full Text] [Related]

  • 19. Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.
    Devesa J, Arce V, Lois N, Tresguerres JA, Lima L.
    J Clin Endocrinol Metab; 1990 Dec 01; 71(6):1581-8. PubMed ID: 1977761
    [Abstract] [Full Text] [Related]

  • 20. Long-term downregulation of central adrenoceptor function by desipramine treatment: a clonidine study in normal subjects.
    Schittecatte M, Charles G, Nefve C, Valentin JG, Machowski R, Wilmotte J.
    Biol Psychiatry; 1992 Apr 15; 31(8):856-8. PubMed ID: 1322721
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.